We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

MEDLAB Middle East and Arab Health 2022 Edition Return as Co-Located Events for Healthcare and Laboratory Industries

By LabMedica International staff writers
Posted on 24 Jan 2022
Print article
Image: MEDLAB Middle East (Photo courtesy of Informa Markets)
Image: MEDLAB Middle East (Photo courtesy of Informa Markets)

Technology took centre stage at the 2022 edition of Arab Health and MEDLAB Middle East, the largest healthcare and laboratory exhibitions in the MENA region, organized by Informa Markets (London, UK).

The co-located events took place at the Dubai World Trade Centre from January 24-27 under the show themes of ‘United by business, forging ahead’ and ‘Connect with innovation that’s changing the face of diagnostics’. Both shows saw participants from nearly 160 countries and more than 60,000 attendees across the four days, with almost 4,000 exhibitors from the healthcare and laboratory industries.

More than 60 countries were represented, with over 20 dedicated country pavilions, making Arab Health and MEDLAB Middle East a genuinely global healthcare showcase. They included the UAE, Israel, Lebanon, Turkey, and a host of European countries such as the UK, Switzerland, Germany, Italy, France, Spain, Portugal, Slovenia, Hungary, Czech Republic, Poland, and Belgium. Russia, China, Taiwan, Japan, Korea, India, the US and Canada also had several exhibitors showcasing the latest technology and innovation through a range of healthcare products. Each pavilion hosted between 16 and 33 healthcare-related companies. In addition, the European Innovation Council Pavilion hosted 20 selected companies from across the healthcare landscape.

Underscoring the focus on technology, Arab Health 2022 featured the new Healthcare Transformation Zone which explored the latest tech advancements from global innovators and disruptors. The popular start-up competition, Innov8 Talks returned and featured 24 companies showcasing unique and innovative solutions. Rounding out the Transformation Zone was the launch of the Product Showcase segment, where a range of companies showcased ground-breaking innovations shaping the future of the healthcare and laboratory industries.

In another first for both events was the launch of the Future Health Summit. The high-level event was attended by over 150 senior government healthcare officials, CEOs and visionaries, from across the globe. As part of the Arab Health Congress, more than 550 regional and international speakers and over 2,500 delegates participated in 12 Continuing Medical Education (CME). With a total of nine conferences, MEDLAB Middle East Congress remains one of the largest CME accredited multi-track medical laboratory congresses globally, featuring over 100 renowned laboratory champions from around the world. Eight conferences took place live, in-person, and online, the new bonus track, Future of Lab.

"Arab Health and Medlab Middle East will once again reiterate the importance of the healthcare and laboratory industries as we continue to address the challenges posed by COVID-19 and provide a platform for developing solutions to overcome the pandemic," said Solenne Singer, Group Director for Informa Markets. "We have witnessed a clear uptick in demand from both buyers and exhibitors eager to meet in-person, to see firsthand the latest technology and innovation on the market, while also hearing from industry professionals from around the world on the latest trends and insights. This year, both events will be integral to ongoing global recovery, and we look forward to welcoming the industry to Dubai."

Related Links:
Informa Markets 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Myeloperoxidase Assay
IDK MPO ELISA

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The AI-based method can more accurately detect antibiotic resistance in deadly bacteria such as tuberculosis and staph (Photo courtesy of Adobe Stock)

New AI-Based Method Improves Diagnosis of Drug-Resistant Infections

Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more

Technology

view channel
Image: Pictorial representation of the working principle of a functionalized Carbon Dots CDs and EB based Func sensor (Photo courtesy of Toppari/University of Jyväskylä)

Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection

Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Sekisui Diagnostics UK Ltd.